Published in Cardiorenal Med on May 16, 2013
Effect of the FTO rs9930506 Polymorphism on the Main Comorbidities of the Cardiorenal Metabolic Syndrome in an Elderly Spanish Cohort. Cardiorenal Med (2014) 0.75
Association between Apolipoprotein E Polymorphism and Chronic Kidney Disease in the Korean General Population: Dong-gu Study. Korean J Fam Med (2014) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet (2000) 6.61
Apolipoprotein E genotyping by one-stage PCR. Lancet (1991) 4.20
Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem (1982) 2.71
Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart Study. J Am Soc Nephrol (2004) 2.36
Apolipoprotein E and progression of chronic kidney disease. JAMA (2005) 2.14
Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia (2010) 1.60
Lipoprotein metabolism and renal failure. Am J Kidney Dis (1993) 1.37
Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation. Proc Natl Acad Sci U S A (2011) 1.33
A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion. J Biol Chem (2001) 1.23
Apolipoprotein E and renal disease. Am J Kidney Dis (2004) 1.20
APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population. Lipids Health Dis (2010) 1.14
Apolipoprotein E modulates immune activation by acting on the antigen-presenting cell. Immunology (2003) 1.08
Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy. Clin Genet (1995) 1.00
Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice. Nephrol Dial Transplant (2002) 0.97
Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study. BMC Med Genet (2009) 0.96
Distinct apolipoprotein E isoform preference for inhibition of smooth muscle cell migration and proliferation. Biochemistry (2002) 0.96
Association of genetic variants with chronic kidney disease in Japanese individuals. Clin J Am Soc Nephrol (2009) 0.93
Apolipoprotein E polymorphism and renal disease. Kidney Int Suppl (1999) 0.93
Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis. Mol Biol Rep (2010) 0.91
Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus. Atherosclerosis (1994) 0.90
Association of gene polymorphisms with chronic kidney disease in high- or low-risk subjects defined by conventional risk factors. Int J Mol Med (2009) 0.87
Apolipoprotein E and kidney function in older adults. Clin Nephrol (2012) 0.86
Estimated Glomerular Filtration Rate in Short-Risk Stratification in Acute Myocardial Infarction. Cardiorenal Med (2011) 0.85
Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clin Chem (2000) 0.85
Apolipoprotein E polymorphism is related to plasma lipids and apolipoproteins in Mexican adolescents. Hum Biol (2004) 0.85
Abnormal lipid metabolism and renal disorders. Tohoku J Exp Med (1997) 0.84
Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus. Nephrol Dial Transplant (1999) 0.84
Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity. Kidney Int (2001) 0.82
Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation. Nephrol Dial Transplant (2009) 0.82
Cardiorenal Syndrome: The Clinical Cardiologists' Perspective. Cardiorenal Med (2011) 0.79
Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy. Am J Kidney Dis (1991) 0.78
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
The 2011 magnitude 9.0 Tohoku-Oki earthquake: mosaicking the megathrust from seconds to centuries. Science (2011) 5.12
Apolipoprotein epsilon4 allele is associated with psoriasis severity. Arch Dermatol Res (2010) 2.66
Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab (2013) 2.64
[Estimating utility values for health status using the Spanish version of the SF-36. Validity of the SF-6D index vs EQ-5D]. Med Clin (Barc) (2007) 2.07
A new basal sauropod dinosaur from the middle Jurassic of Niger and the early evolution of sauropoda. PLoS One (2009) 1.92
The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab (2008) 1.85
Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol (2004) 1.82
Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol (2012) 1.68
A new mutation (intron 9 +1 G>T) in the SLC12A3 gene is linked to Gitelman syndrome in Gypsies. Kidney Int (2004) 1.63
Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens (2007) 1.60
Mutation analysis of the main hypertrophic cardiomyopathy genes using multiplex amplification and semiconductor next-generation sequencing. Circ J (2014) 1.50
Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial. Nephrol Dial Transplant (2003) 1.39
The braincase of the basal sauropod dinosaur Spinophorosaurus and 3D reconstructions of the cranial endocast and inner ear. PLoS One (2012) 1.39
Neurocranial osteology and neuroanatomy of a late Cretaceous titanosaurian sauropod from Spain (Ampelosaurus sp.). PLoS One (2013) 1.32
Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One (2012) 1.23
In vivo interleukin-6 protects neutrophils from apoptosis in osteomyelitis. Infect Immun (2004) 1.22
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis. Clin Exp Immunol (2006) 1.15
New evidence of shared dinosaur across Upper Jurassic Proto-North Atlantic: Stegosaurus from Portugal. Naturwissenschaften (2006) 1.13
Circulating omentin concentration increases after weight loss. Nutr Metab (Lond) (2010) 1.13
Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia. Neurobiol Aging (2013) 1.12
Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells. PLoS One (2010) 1.11
Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity (Silver Spring) (2011) 1.11
Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population. J Neurol Sci (2005) 1.10
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Aneurysm of the petrous portion of the internal carotid artery at the foramen lacerum: anatomic, imaging, and otologic findings. Ear Nose Throat J (2010) 1.08
MIRAgel: hydrolytic degradation and long-term observations. Arch Ophthalmol (2007) 1.06
A spastic paraplegia mouse model reveals REEP1-dependent ER shaping. J Clin Invest (2013) 1.03
Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients. Clin Chem (2003) 1.03
Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance. Diabetes (2010) 1.02
Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant (2009) 1.01
Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease. Mov Disord (2011) 1.01
A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia (2013) 1.00
LRRK2 R1441G in Spanish patients with Parkinson's disease. Neurosci Lett (2005) 1.00
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol Aging (2011) 1.00
Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls. J Neurol (2013) 0.99
The contribution of the arrector pili muscle and sebaceous glands to the follicular unit structure. J Am Acad Dermatol (2004) 0.98
Relaxation dynamics of langmuir polymer films: a power-law analysis. Phys Rev Lett (2003) 0.97
Role of the CDKN1A/p21, CDKN1C/p57, and CDKN2A/p16 genes in the risk of atherosclerosis and myocardial infarction. Cell Cycle (2007) 0.97
Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice. J Pineal Res (2006) 0.97
Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy. Int J Cardiol (2005) 0.96
Long-time relaxation dynamics of langmuir films of a glass-forming polymer: evidence of glasslike dynamics in two dimensions. Phys Rev Lett (2004) 0.96
Spirometry. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol (2013) 0.95
Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease. Neurosci Lett (2004) 0.95
Spanish validation of the "kidney transplant questionnaire": a useful instrument for assessing health related quality of life in kidney transplant patients. Health Qual Life Outcomes (2003) 0.95
The timely construction of arteriovenous fistulae: a key to reducing morbidity and mortality and to improving cost management. Nephrol Dial Transplant (2005) 0.95
[Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy]. Rev Esp Cardiol (2009) 0.94
The arrector pili muscle and the follicular unit of the scalp: a microscopic anatomy study. Dermatol Surg (2002) 0.94
FGF20 rs12720208 SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients. Neurosci Lett (2010) 0.94
Mutational screening of the mortalin gene (HSPA9) in Parkinson's disease. J Neural Transm (Vienna) (2009) 0.93
Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project. Neurobiol Aging (2010) 0.93
Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes. Clin Chem Lab Med (2011) 0.93
Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation. Strahlenther Onkol (2014) 0.93
A single-nucleotide polymorphism in the human p27kip1 gene (-838C>A) affects basal promoter activity and the risk of myocardial infarction. BMC Biol (2004) 0.92
IL-1 alpha (-889) promoter polymorphism is a risk factor for osteomyelitis. Am J Med Genet A (2003) 0.92
Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin. J Neurochem (2006) 0.91
A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease. J Mol Neurosci (2011) 0.91
Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2. Neurosci Lett (2006) 0.91
[Home vs hospital-based pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: a Spanish multicenter trial]. Arch Bronconeumol (2008) 0.91
Surface rheology of two-dimensional percolating networks: Langmuir films of polymer pancakes. Phys Rev Lett (2005) 0.91
Epigenetic modulation of the immune function: a potential target for tolerance. Epigenetics (2013) 0.90
Resistance training improves cardiovascular risk factors in obese women despite a significative decrease in serum adiponectin levels. Obesity (Silver Spring) (2009) 0.90
Differential role of serotonergic polymorphisms in alcohol and heroin dependence. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.90
No association between Parkinson's disease and three polymorphisms in the eNOS, nNOS, and iNOS genes. Neurosci Lett (2006) 0.90
Mitochondrial haplogroup T is negatively associated with the status of elite endurance athlete. Mitochondrion (2007) 0.90
Achievement of therapeutic goals and utilization of evidence-based cardiovascular therapies in coronary heart disease patients with chronic kidney disease. Am J Cardiol (2008) 0.90
Analysis of the Micro-RNA-133 and PITX3 genes in Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet (2010) 0.90
DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells. Epigenetics (2012) 0.89
Pharmacogenetics of calcineurin inhibitors in renal transplantation. Transplantation (2009) 0.89
Urinary albumin excretion and glomerular filtration rate across the spectrum of glucose abnormalities in essential hypertension. J Am Soc Nephrol (2006) 0.89
Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease. J Neuroinflammation (2009) 0.89
Mutation analysis of the LCE3B/LCE3C genes in Psoriasis. BMC Med Genet (2010) 0.89
Role of training activities for the reduction of pre-analytical errors in laboratory samples from primary care. Clin Chim Acta (2011) 0.88
IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome. Genet Med (2008) 0.88
Consensus document for the detection and management of chronic kidney disease. Nefrologia (2014) 0.88
5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. Clin Sci (Lond) (2003) 0.88
Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: evidence for an association to haplogroup H. Mitochondrion (2010) 0.88
The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project. BMC Med Genet (2010) 0.88
Renin-angiotensin system polymorphisms and renal scarring. Pediatr Nephrol (2002) 0.87
The NOS3 (27-bp repeat, intron 4) polymorphism is associated with susceptibility to osteomyelitis. Nitric Oxide (2006) 0.87
Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia. BMC Neurol (2010) 0.87
Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain. Neurogenetics (2009) 0.86
Exercise training in mitochondrial myopathy: a randomized controlled trial. Muscle Nerve (2005) 0.86
Adsorption kinetics and mechanical properties of ultrathin polyelectrolyte multilayers: liquid-supported versus solid-supported films. J Phys Chem B (2009) 0.86
[Evaluation and management of hypertension in Spain. A consensus guide]. Med Clin (Barc) (2008) 0.86
Characterization of herpes virus entry mediator as a factor linked to obesity. Obesity (Silver Spring) (2009) 0.86
Study of lactoferrin gene expression in human and mouse adipose tissue, human preadipocytes and mouse 3T3-L1 fibroblasts. Association with adipogenic and inflammatory markers. J Nutr Biochem (2013) 0.85
KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients. Clin Transplant (2011) 0.85
Myocyte enhancing factor-2A in Alzheimer's disease: genetic analysis and association with MEF2A-polymorphisms. Neurosci Lett (2006) 0.85
Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease. Neurobiol Aging (2012) 0.85